BioAge Labs, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-270012
- Form type
- 10-Q
- CIK
- 0001709941
- Primary document
- https://www.sec.gov/Archives/edgar/data/1709941/000119312525270012/bioa-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioAge Labs, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $5.9M | - | - |
| Operating Income | $-64.4M | - | - |
| Net Income | $-54.7M | - | - |
| Eps Basic | -1.52 | - | - |
| Eps Diluted | -1.52 | - | - |
| Cash And Equivalents | $215.6M | - | - |
| Total Assets | $305.1M | - | - |
| Total Liabilities | $27.6M | - | - |
| Shareholders Equity | $277.5M | - | - |
| Operating Cash Flow | $-53.4M | - | - |
| Capital Expenditures | $607,000 | - | - |